West Pharmaceutical Services (WST) Goodwill (2009 - 2026)

West Pharmaceutical Services (WST) has reported Goodwill for 18 consecutive years, with $108.7 million the latest figure, recorded in Q2 2026.

• Quarterly Goodwill fell 1.98% year-over-year to $108.7 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $108.7 million (down 1.98% YoY) and the FY2025 annual result came in at $109.9 million, up 3.68% from the prior year.
• Goodwill held at $108.7 million in Q2 2026 per WST's latest filing, from $109.2 million in the prior quarter.
• Over the last five years, Goodwill for WST reached as high as $110.9 million in Q2 2025 and fell as low as $104.0 million in Q3 2022.
• A 5-year average of $108.0 million and a median of $107.9 million in 2023 frame the typical range for Goodwill.
• Annual changes were most pronounced in 2022 — Goodwill slipped 4.5% — and 2025, when it gained 3.68%.
• Year by year, Goodwill stood at $107.3 million in 2022, then gained by 1.12% to $108.5 million in 2023, then fell by 2.3% to $106.0 million in 2024, then grew by 3.68% to $109.9 million in 2025, then fell by 1.09% to $108.7 million in 2026.
• According to Business Quant data, Goodwill over the past three periods registered $108.7 million, $109.2 million, and $109.9 million for Q2 2026, Q1 2026, and Q4 2025 respectively.